| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $245.1M | +20.4% |
| Cost of Revenue | $155.4M | +30.2% |
| R&D Expense | $106.9M | -11.1% |
| SG&A Expense | $189.7M | -10.9% |
| Operating Income | -$217.2M | +7.5% |
| Interest Expense | $5K | -93.8% |
| Pre-tax Income | -$203.5M | +10.9% |
| Income Tax | $1.2M | +111.1% |
| Net Income | -$204.6M |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $286.5M | -24.4% |
| Short-term Investments | $49.9M | -60.5% |
| Accounts Receivable | $44.1M | +9.4% |
| Inventory | $32.1M | -18.4% |
| Current Assets | $424.3M | -28.9% |
| Total Assets | $776.4M | -19.2% |
| Current Liabilities | $73.3M | -19.1% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$142.5M | -14.5% |
| Capital Expenditures | $27.8M | -72.7% |
| Investing Cash Flow | $50.6M | +121.7% |
| Financing Cash Flow | $911K | -99.7% |
| Free Cash Flow | -$170.3M | +24.7% |
| +6.1% |
| EPS (Basic) | -$3.60 | +10.9% |
| EPS (Diluted) | -$3.60 | +10.9% |
| Total Liabilities |
| $153.0M |
| -11.1% |
| Stockholders' Equity | $623.4M | -21.0% |